Exploring the relationship between anorexia and therapeutic efficacy in advanced lung cancer treatment: a retrospective study.

ABSTRACT:

Background

Chemotherapy-induced anorexia is a common occurrence in patients undergoing treatment for advanced lung cancer. However, the relationship between chemotherapy-induced anorexia and weight loss during platinum-based chemotherapy combined with immune checkpoint inhibitors is unclear. This study explored the relationship between chemotherapy-induced anorexia and therapeutic outcomes in patients with stage IV non-small-cell lung cancer undergoing platinum-based chemotherapy combined with immune checkpoint inhibitors.

Methods

The study retrospectively reviewed the medical records of 106 patients with stage IV non-small-cell lung cancer treated with platinum-based chemotherapy and immune checkpoint inhibitors between January 2019 and October 2022. The incidence of weight

SUBMITTER: Doshita K 

PROVIDER: S-EPMC11367660 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature